Literature DB >> 17442956

Human TCR-binding affinity is governed by MHC class restriction.

David K Cole1, Nicholas J Pumphrey, Jonathan M Boulter, Malkit Sami, John I Bell, Emma Gostick, David A Price, George F Gao, Andrew K Sewell, Bent K Jakobsen.   

Abstract

T cell recognition is initiated by the binding of TCRs to peptide-MHCs (pMHCs), the interaction being characterized by weak affinity and fast kinetics. Previously, only 16 natural TCR/pMHC interactions have been measured by surface plasmon resonance (SPR). Of these, 5 are murine class I, 5 are murine class II, and 6 are human class I-restricted responses. Therefore, a significant gap exists in our understanding of human TCR/pMHC binding due to the limited SPR data currently available for human class I responses and the absence of SPR data for human class II-restricted responses. We have produced a panel of soluble TCR molecules originating from human T cells that respond to naturally occurring disease epitopes and their cognate pMHCs. In this study, we compare the binding affinity and kinetics of eight class-I-specific TCRs (TCR-Is) to pMHC-I with six class-II-specific TCRs (TCR-IIs) to pMHC-II using SPR. Overall, there is a substantial difference in the TCR-binding equilibrium constants for pMHC-I and pMHC-II, which arises from significantly faster on-rates for TCRs binding to pMHC-I. In contrast, the off-rates for all human TCR/pMHC interactions fall within a narrow window regardless of class restriction, thereby providing experimental support for the notion that binding half-life is the principal kinetic feature controlling T cell activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442956     DOI: 10.4049/jimmunol.178.9.5727

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  115 in total

1.  Bi-specific MHC heterodimers for characterization of cross-reactive T cells.

Authors:  Zu T Shen; Michael A Brehm; Keith A Daniels; Alexander B Sigalov; Liisa K Selin; Raymond M Welsh; Lawrence J Stern
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  Reversed-polarity T(reg) cell TCRs provide a shock.

Authors:  Mark Peakman; Andrew K Sewell
Journal:  Nat Immunol       Date:  2015-11       Impact factor: 25.606

3.  Cell surface display of functional human MHC class II proteins: yeast display versus insect cell display.

Authors:  Fei Wen; Dhruv K Sethi; Kai W Wucherpfennig; Huimin Zhao
Journal:  Protein Eng Des Sel       Date:  2011-07-13       Impact factor: 1.650

Review 4.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

5.  Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.

Authors:  David K Cole; Fang Yuan; Pierre J Rizkallah; John J Miles; Emma Gostick; David A Price; George F Gao; Bent K Jakobsen; Andrew K Sewell
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

Review 6.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

7.  Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex.

Authors:  Xin Xiang Wang; Yili Li; Yiyuan Yin; Min Mo; Qian Wang; Wei Gao; Lili Wang; Roy A Mariuzza
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-07       Impact factor: 11.205

Review 8.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Authors:  Ingunn M Stromnes; Thomas M Schmitt; Aude G Chapuis; Sunil R Hingorani; Philip D Greenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

Authors:  Mathilde Allard; Barbara Couturaud; Laura Carretero-Iglesia; Minh Ngoc Duong; Julien Schmidt; Gwennaëlle C Monnot; Pedro Romero; Daniel E Speiser; Michael Hebeisen; Nathalie Rufer
Journal:  JCI Insight       Date:  2017-07-20

10.  T cell receptor triggering by force.

Authors:  Zhengyu Ma; Terri H Finkel
Journal:  Trends Immunol       Date:  2010-01       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.